Interestingly, IL4I1 is secreted and found in serum52 where it promotes a tumor-prone microenvironment, increasing the concentration of metabolites in the patient’s biological fluids, including malignant gliomas patients’ cerebrospinal fluid53–55. This evidence concerns the gene IL4I1 and neoplasm.